Form 4 for DGX Quest Diagnostics
Accepted 2024-03-01 00:00:00 ET · period of report 2024-02-28 · accession 0001022079-24-000083 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-01 | 2024-02-28 | DGX | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $126.36 | -861 | 44.5K | -2% | -$108.8K |
| 2024-03-01 | 2024-02-29 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $125.88 | -5,611 | 38.5K | -13% | -$706.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | F | D | 456 | $126.36 | 44,089 | D | — | — | (F1) Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. |
| 2 | Common | Common Stock | 2024-02-28 | F | D | 405 | $126.36 | 44,545 | D | — | — | (F1) Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. |
| 3 | Common | Common Stock | 2024-02-29 | S | D | 5,611 | $125.88 | 38,478 | D | — | — |